Keywords: درمان های نوین; Mantle cell lymphoma; Novel therapeutics; Clinical trials;
مقالات ISI درمان های نوین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان های نوین; ACSVL3; acyl-coA synthetase VL3; ALDH1; aldehyde dehydrogenase; ALDOA; aldolase A; ALDOC; aldolase C; AMPK; 5â² AMP-activated protein kinase; ASNS; asparagine synthetase; BTICs; brain tumor initiating cells; 3-BrOP; 3-bromo-2-oxopropionate-1-propyl ester
Keywords: درمان های نوین; ADAM; a disintegrin and metalloprotease; ADEX; aberrantly differentiated endocrine exocrine; ALDH1; aldehyde dehydrogenase 1; CAFs; cancer associated fibroblasts; CDKN2A; cyclin dependent kinase inhibitor 2A; CSC; cancer stem cell; CTC; circulating tumor
Keywords: درمان های نوین; Leukemia; Microenvironment; Cancer; Inflammation; Immune surveillance; Novel therapeutics;
Keywords: درمان های نوین; High-risk prostate cancer; Neoadjuvant therapy; Chemotherapy; Novel therapeutics;
Keywords: درمان های نوین; Pancreatic adenocarcinoma; Novel therapeutics; Immunotherapy; BRCA; Stromal targeting; KRAS;
Keywords: درمان های نوین; Castration resistant prostate cancer; Molecular biology; Androgen receptor; Novel therapeutics;
Review articleGlutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies
Keywords: درمان های نوین; Posttraumatic stress disorder (PTSD); Glutamate; Glutamine; GABA; NMDA; Neurobiology; Neurotransmission; Novel therapeutics; Treatment; Ketamine; d-Cycloserine;
Original ArticleNovel flexible heteroarotinoid, SL-1-18, promotes ERα degradation to inhibit breast cancer cell growth
Keywords: درمان های نوین; Flexible heteroarotinoid; Breast cancer; Estrogen receptor; SHetA2; Selective ER down-regulators; Novel therapeutics; SL-1-18; 1-(chrysen-6-yl)-3-(4-nitrophenyl)thiourea; Flex-Het; flexible heteroarotinoid; ER; estrogen receptor; SERMs; selective estrogen
Original ArticlemicroRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer
Keywords: درمان های نوین; Pancreatic cancer; microRNA; Multi drug resistance; Novel therapeutics; Bx-GEM; gemcitabine resistant BxPC3 subclone; CAM; chorioallantoic membrane; miR; micro-RNA; PDA; pancreatic ductal adenocarcinoma; RRM1; ribonucleotide reductase sub-unit M1; 3â² UT
The current status of oncolytic viral therapy for head and neck cancer
Keywords: درمان های نوین; Head and neck squamous cell carcinoma; Oncolytic viruses; Clinical trials; Novel therapeutics
SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
Keywords: درمان های نوین; Prostate cancer; Angiogenesis; Alternative splicing; Novel therapeutics;
Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations
Keywords: درمان های نوین; Mesothelioma; BRCA-associated protein 1; Novel therapeutics
Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer
Keywords: درمان های نوین; Advanced NSCLC; Antisense oligonucleotide; Novel therapeutics; Chemotherapy; Biomarker
Reorganized PKA-AKAP associations in the failing human heart
Keywords: درمان های نوین; Heart failure; Novel therapeutics; Cyclic nucleotides; AKAP; Chemical proteomics; Label-free quantitation;
Can Existing Drugs Approved for Other Indications Retard Renal Function Decline in Patients With Type 1 Diabetes and Nephropathy?
Keywords: درمان های نوین; Diabetic nephropathy; uric acid; inflammation; immune system; novel therapeutics;
Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma
Keywords: درمان های نوین; Polo-like kinase 1; PLK1; Multiple myeloma; Novel therapeutics
NIH and NCI support for development of novel therapeutics in gynecologic cancer: A user's guide
Keywords: درمان های نوین; Novel therapeutics; NIH and NCI resources; Grants;
Promising novel therapies for the treatment of endometrial cancer
Keywords: درمان های نوین; Endometrial cancer; Biologic therapy; Chemotherapy; Novel therapeutics; Molecular targets
Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists
Keywords: درمان های نوین; Formyl peptide; Endogenous anti-inflammation; Annexin A1; New chemical entities; Novel therapeutics; Neutrophil migrationAc2–26, Peptide Ac2–26 of Annexin A1; AnxA1, Annexin A1; βA42, Beta-amyloid 1–42; C43, Compound 43; COX, Cyclo-oxygenase; ATL, Aspirin
Targeting breast cancer stem cells
Keywords: درمان های نوین; Cancer stem cell (CSC); Breast cancer; Novel therapeutics
Looking Toward the Future: Novel Strategies Based on Molecular Pathogenesis of Acute Lymphoblastic Leukemia
Keywords: درمان های نوین; Prognostic factors; Risk-adapted therapies; Novel therapeutics;
Treatment of Intermediate-Risk Non–Muscle-Invasive Bladder Cancer (NMIBC)
Keywords: درمان های نوین; Non–muscle-invasive; Bladder cancer; Intravesical therapy; Chemotherapy; Novel therapeutics; Urothelial cell carcinoma
Are mouse models of allergic asthma useful for testing novel therapeutics?
Keywords: درمان های نوین; Drug testing; Novel therapeutics; Asthma bronchiale; Mouse models; T cells;